Register | Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC

Specialties >>

AML
Biomarker-Driven Lung Cancer
Bladder Cancer
Breast Cancer
CAR T-Cell Therapy
CLL
Colorectal Cancer
DLBCL
EGFR+ Lung Cancer
Follicular Lymphoma
Genomic Testing
GI Cancers
Gynecologic Cancers
HCC
Hematology
Immunotherapy
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
Melanoma
MPNs
Multiple Myeloma
Prostate Cancer
Renal Cell Carcinoma
Skin Cancers
Thyroid Cancers
More >>

Partners >>

Dialogues in Diagnostics
Differential Diagnosis
Case-Based Peer Perspectives
Email Sign-Up

Latest NewsMORE >>

Lenvatinib Plus Nivolumab Demonstrates Antitumor Activity in Unresectable HCC
January 25, 2020
Lenvatinib in combination with nivolumab demonstrated promising antitumor activity in patients with unresectable hepatocellular carcinoma with no new safety signals reported.
Read more >>
Feature:

Coverage from the 2020 ASCO Gastrointestinal Cancers Symposium Learn More >>

Patients With HCC Experience Better OS With Anticancer Procedure After Lenvatinib
January 25, 2020
PARP Added to Chemotherapy Results in Positive Responses for Pancreatic Cancer
January 25, 2020
Adding Dietary Supplements to Treatment Impacts Outcomes in Unresectable Pancreatic Cancer
January 25, 2020
Durable Responses Achieved With Triplet Combination in Gastric Cancer
January 24, 2020

Videos

Microsatellite Instability Serves as a Predictive Biomarker of Response to Pembrolizumab
Adjuvant Durvalumab Strategy in Locally Advanced Esophageal GEJ Adenocarcinoma
The Role of Molecular Driver Identification Continues to Expand in NSCLC
Anti-CD20 Agent Yields High Responses in Follicular Lymphoma

Case Studies

Case: Relapsed/Refractory Waldenstrom Macroglobulinemia
Elucidating a Case of Locally Advanced CSCC
Prognosis for Stage IV Hodgkin's Lymphoma & Patient Expectations
Managing Extranodal MZL

Latest JournalAll Journals >>

Targeted Therapies in Oncology January 2020
Targeted Therapies in Oncology
Miami Breast Cancer Conference: Applying Research Shared on Friday to Patient Care on Monday
First Randomized Clinical Trial Evaluating Geriatric Assessment Reveals High Satisfaction With Communication About Aging-Related Concerns
NRG1 Emerges as a Potentially Actionable Target in Lung Cancer and Solid Tumors
Encouraging Results in First-Line Setting for HCC Usher Lenvatinib Toward Randomized Controlled Trials
Nivolumab/Ipilimumab Combo Extends Treatment-Free Survival in RCC
Telehealth Delivers Access to Care and Cutting-Edge Clinical Research to Rural Areas
MORE >>
Copyright © TargetedOnc 2020 Intellisphere, LLC. All Rights Reserved.